Intravenous mesenchymal stem cell therapy for traumatic brain injury
about
Increased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell ImagingAlzheimer's Disease: Mechanism and Approach to Cell TherapyClinical imaging in regenerative medicineImmunotherapeutic organoids: a new approach to cancer treatmentCell-based therapy for traumatic brain injuryCell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsPulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.Cyclooxygenase-2 or tumor necrosis factor-α inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic muscleCalcitonin gene-related peptide is a key factor in the homing of transplanted human MSCs to sites of spinal cord injury.Improving the therapeutic efficacy of mesenchymal stromal cells to restore perfusion in critical limb ischemia through pulsed focused ultrasound.Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound.Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing.Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model.Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.Optimizing the success of cell transplantation therapy for stroke.Mesenchymal Stromal Cell Dependent Regression of Pulmonary Metastasis from Ewing's.Therapeutic Prospective of Infused Allogenic Cultured Mesenchymal Stem Cells in Traumatic Brain Injury Mice: A Longitudinal Proton Magnetic Resonance Spectroscopy AssessmentSystemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse ModelsIntra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokesBone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma.Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor.Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shockIntravenous transplantation of bone marrow mesenchymal stem cells promotes neural regeneration after traumatic brain injuryStem cells in neuroinjury and neurodegenerative disorders: challenges and future neurotherapeutic prospects.Human Bone Marrow Derived Mesenchymal Stem Cells Regulate Leukocyte-Endothelial Interactions and Activation of Transcription Factor NF-Kappa B.Tracking intravenous adipose-derived mesenchymal stem cells in a model of elastase-induced emphysemaImaging of cells and nanoparticles: implications for drug delivery to the brain.Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.Quantitative Magnetic Particle Imaging Monitors the Transplantation, Biodistribution, and Clearance of Stem Cells In VivoFailure of intravenous or intracardiac delivery of mesenchymal stromal cells to improve outcomes after focal traumatic brain injury in the female rat.Systematic review and meta-analysis of efficacy of mesenchymal stem cells on locomotor recovery in animal models of traumatic brain injury.Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain.Intra-Arterial Administration of Multipotent Mesenchymal Stromal Cells Promotes Functional Recovery of the Brain After Traumatic Brain Injury.The preclinical discovery of amyotrophic lateral sclerosis drugs.Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope?Angiopoietin-1 Modified Human Umbilical Cord Mesenchymal Stem Cell Therapy for Endotoxin-Induced Acute Lung Injury in Rats.Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis.Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemiaSafety of Intraperitoneal Injection of Adipose Tissue-Derived Autologous Mesenchymal Stem Cells in Cats.
P2860
Q26753150-670F8831-43BE-44C6-B83F-B4DD7050BA30Q26778149-E0B7D7C6-138D-490A-9719-9F2E2AB05CC1Q26851906-E7717A90-4A35-45E6-9ED7-8E5F0DA0AEEFQ26853431-9F98DDD3-9B0C-492B-8EF9-E0AAC0050F61Q26998959-559717C2-9B7A-472D-9303-C030C346FBB8Q27026350-9F22FE05-F430-46FD-BC76-04A94973D851Q27329535-4E6E9772-D503-4052-BB1D-A5C2A5961852Q27329655-87D14C93-F623-4C37-B9FB-61D4856DDF5AQ27342569-AFF71E83-AA57-4EEF-8C68-7251D246E9E8Q30363630-5F20522E-EA13-44F6-926A-9374359BF491Q30454160-E84A819C-EA13-4F6F-8C41-4ECFEAADB52CQ30530998-3FB70F45-A0B1-4E48-B9C9-349285E7A638Q30580565-8A870320-8C8B-4E80-9CB3-97B9D940A376Q33560685-6BBDC357-1622-4643-BB4B-546D92E8D097Q33636930-5215E211-DE63-4010-8E61-A2CCB770B272Q33688230-B78FF77D-9022-414B-905E-A20BFE34F3FEQ33722258-AF142E61-5F3A-4951-B369-F585B3410DB4Q33722638-AC1E8821-CFA2-4031-A0D2-BE310C6332C2Q33771764-865A3686-5BB0-4374-8AD3-7C8D672FC532Q33777681-FF48DF87-86BA-4B2C-901E-BDDF6DCF7D61Q33907262-1E90A762-D792-4EFC-8219-CAB109E2B942Q34042955-746BFC66-ABD4-48A2-B219-B7839F65387CQ34095987-3E14C1AA-810E-4913-BDD7-C92964E2394CQ34095999-899DEE04-9177-4D90-8140-74297666E18EQ34306920-6CF0DE98-EEDF-4328-BE0C-82B2EB6754F2Q34316601-8A179CED-F543-47AD-A2B9-58646481BE69Q34340761-9A3B1AFF-F703-402E-97F8-467AAC99FAE0Q34345561-A235A5F8-B410-4AA3-AE79-E47A72255C64Q34432396-24EDE4BF-79DC-4002-ACE7-232B216C3695Q34515367-BCA4489D-857A-48A5-B527-77DD8BFFD4A8Q35577615-C525E933-6A0A-429F-911A-E7BCD7259AE0Q35588483-7E4F768E-3887-4F4E-8355-20321646B355Q35750606-384F188E-EBE6-4814-BBD1-800A3C021D20Q35781673-C60582EC-E9EB-4548-AE7D-E14DBEF5F579Q36009915-D8CBD9EA-319B-4E56-88F5-66E326F32DFEQ36108608-9FAA1164-08C7-4DB3-AD8C-F80C245FA15DQ36200752-5AF88174-6299-4047-911E-E8E07A11FEBDQ36419634-2DA07DE6-9BA6-4BA8-B652-C0AF07699D3AQ36797965-06E8A708-CFA8-4EF3-921C-6EA9AE3D4F1FQ37020401-3BC5E2AE-289B-47D9-9D2D-9BBA08E960A6
P2860
Intravenous mesenchymal stem cell therapy for traumatic brain injury
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Intravenous mesenchymal stem cell therapy for traumatic brain injury
@ast
Intravenous mesenchymal stem cell therapy for traumatic brain injury
@en
type
label
Intravenous mesenchymal stem cell therapy for traumatic brain injury
@ast
Intravenous mesenchymal stem cell therapy for traumatic brain injury
@en
prefLabel
Intravenous mesenchymal stem cell therapy for traumatic brain injury
@ast
Intravenous mesenchymal stem cell therapy for traumatic brain injury
@en
P2093
P2860
P356
P1476
Intravenous mesenchymal stem cell therapy for traumatic brain injury
@en
P2093
Charles S Cox
Fernando Jimenez
James Baumgartner
Matthew T Harting
Pramod K Dash
Uwe M Fischer
P2860
P304
P356
10.3171/2008.9.JNS08158
P577
2009-06-01T00:00:00Z